Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Oct 1, 2020
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-09-30$0.53/sh−301$160→ 167,842 total
4 · Nabriva Therapeutics plc · Filed Oct 1, 2020
Ordinary Shares